Press-release for stocks publishing date 2022 - 06

Prices are updated after-hours

publishing date : 2022 - 06 - 02 tags : Therapeutics

save search

4D Molecular Therapeutics to Participate in Upcoming June Investor Conferences
Published: 2022-06-02 (Crawled : 01:00) - biospace.com/
FDMT | News | $25.29 2.06% 2.02% 630K

Health Technology

| 228.82% | O: -0.66% H: 0.0% C: 0.0%
therapeutics molecular

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-06-02 (Crawled : 22:00) - prnewswire.com
AKBA | $1.36 -2.16% -2.21% 2.9M

Health Technology

| 312.86% | O: 2.92% H: 17.48% C: 17.48%
nasdaq grants therapeutics grant

Poseida Therapeutics Announces Virtual 2022 Annual Meeting of Stockholders
Published: 2022-06-02 (Crawled : 19:00) - biospace.com/
PSTX | News | $2.02 1.0% 0.99% 640K

Health Technology

| -0.73% | O: 1.46% H: 0.48% C: -1.44%
therapeutics

Axsome Therapeutics Presents New Data from the GEMINI Trial Demonstrating Efficacy of AXS-05 on Anhedonia in Patients with Major Depressive Disorder
Published: 2022-06-02 (Crawled : 19:00) - biospace.com/
AXSM | $67.91 3.33% 3.22% 890K

Health Technology

| 173.49% | O: -2.12% H: 0.0% C: 0.0%
axs-05 trial therapeutics major depressive disorder

Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001™ at the 2022 Annual European Hematology Association (EHA) Congress
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
VRTX | News | $394.43 0.24% 0.24% 1.3M

Health Technology

| 46.6% | O: -0.31% H: 0.89% C: 0.55%
CRSP M | $55.04 -1.99% -2.03% 1.8M

Health Technology

| 0.16% | O: -0.59% H: 8.12% C: 6.03%
ctx001 crispr therapeutics

Oncternal Therapeutics to Participate in the Jefferies Healthcare Conference 2022
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
ONCT | News | $8.97 4.3% 4.12% 4.5K

Health Technology

| 473.72% | O: -3.85% H: 8.0% C: -0.67%
conference therapeutics

Qualigen Therapeutics Acquires Majority Stake in Infectious Disease Diagnostics Technology Company NanoSynex
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
QLGN | $0.301 -3.43% -3.55% 30K

Health Technology

| -46.43% | O: 1.52% H: 9.08% C: 3.78%
disease technology diagnostics therapeutics diagnostic

Horizon Therapeutics plc to Highlight Data and Education on Thyroid Eye Disease (TED) at the Endocrine Society (ENDO) 2022 Annual Conference
Published: 2022-06-02 (Crawled : 13:00) - biospace.com/
HZNP | $116.3 0.03% 29M

Health Technology

| 26.76% | O: -3.15% H: 4.36% C: 3.97%
conference disease education endocrine eye therapeutics

Janux Therapeutics to Present at 2022 Jefferies Global Healthcare Conference
Published: 2022-06-02 (Crawled : 13:00) - biospace.com/
JANX | $48.69 -0.33% -0.33% 670K

Professional, Scientific, and T...

| 334.03% | O: -14.3% H: 7.92% C: 7.81%
conference therapeutics

InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study
Published: 2022-06-02 (Crawled : 13:00) - biospace.com/
NVIV | $0.3207 -25.16% 1.9M

Health Technology

| -89.81% | O: 0.0% H: 2.04% C: -5.75%
therapeutics

Viracta Therapeutics Provides an Update on the Phase 1b/2 Trial of Nana-val in Patients with Advanced Epstein-Barr Virus-Positive (EBV+) Solid Tumors and Announces Upcoming Poster Presentation at the ASCO Annual Meeting
Published: 2022-06-02 (Crawled : 13:00) - biospace.com/
VIRX | $0.88 -3.19% -3.3% 53K

Manufacturing

| -55.24% | O: 0.0% H: 3.33% C: 2.86%
trial therapeutics presentation asco phase 2b

Global Roundup: Memo Therapeutics Takes Aim at BKV Infections
Published: 2022-06-02 (Crawled : 12:20) - biospace.com/
EPZM | $1.47 -1.34% 0.0%

Health Technology

| 236.23% | O: -3.34% H: 14.53% C: 10.27%
infections therapeutics

Omega Therapeutics to Participate in the Jefferies Healthcare Conference and Goldman Sachs 43rd Annual Global Healthcare Conference in June 2022
Published: 2022-06-02 (Crawled : 12:00) - biospace.com/
OMGA | $2.4 -0.83% -0.83% 400K

| 9.17% | O: -14.29% H: 18.41% C: 9.95%
conference therapeutics

Vera Therapeutics to Participate in the 2022 Jefferies Healthcare Conference
Published: 2022-06-02 (Crawled : 12:00) - biospace.com/
VERA | $37.96 -3.85% -4.0% 1.4M

Professional, Scientific, and T...

| 172.36% | O: -4.02% H: 2.91% C: 1.06%
conference therapeutics

Michael Severino, M.D., Joins Flagship Pioneering-Founded Tessera Therapeutics as Chief Executive Officer
Published: 2022-06-02 (Crawled : 12:00) - biospace.com/
OMGA | $2.4 -0.83% -0.83% 400K

| 9.17% | O: -14.29% H: 18.41% C: 9.95%
SANA | $7.605 -1.62% -1.64% 3.4M

| 55.12% | O: -6.1% H: 9.2% C: 8.6%
MCRB | $0.5671 -2.93% -3.02% 3.7M

Health Technology

| -81.79% | O: -2.98% H: 5.18% C: 3.24%
RUBY | $0.057 -99.3% 760K

Health Technology

| -95.0% | O: -12.16% H: 2.29% C: -5.11%
MRNA S | $101.44 -0.55% -0.55% 2.6M

Health Technology

| -28.91% | O: -3.65% H: 1.64% C: -0.01%
FHTX | $5.335 -3.53% -3.66% 120K

Health Technology

| -54.33% | O: -3.44% H: 4.99% C: -2.54%
EVLO | $0.3165 -87.39% 710K

Health Technology

| -85.48% | O: 13.76% H: 8.47% C: 7.66%
DNLI | $15.98 -3.74% -3.88% 1.5M

Health Technology

| -29.28% | O: -3.1% H: 2.86% C: 2.15%
therapeutics

Silence Therapeutics to Present at Jefferies Healthcare Conference
Published: 2022-06-02 (Crawled : 12:00) - biospace.com/
SLN | $22.75 3.32% 3.21% 310K

Health Technology

| 122.27% | O: 8.25% H: 0.0% C: -7.67%
conference therapeutics

Sage Therapeutics to Present at Upcoming June 2022 Investor Conferences
Published: 2022-06-02 (Crawled : 11:00) - biospace.com/
SAGE | $13.35 2.42% 2.36% 1.3M

Health Technology

| -60.9% | O: 6.39% H: 7.56% C: 7.34%
therapeutics